Michael J. Wehle
University of Chicago
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael J. Wehle.
The Journal of Urology | 2000
Gary D. Steinberg; Robert Bahnson; Stanley A. Brosman; Richard P. Middleton; Zev Wajsman; Michael J. Wehle
Purpose: We assess the efficacy and safety of intravesical valrubicin for the treatment of carcinoma in situ in patients with failure or recurrence after bacillus Calmette-Guerin (BCG) and who othe...
Radiotherapy and Oncology | 2009
Jennifer L. Peterson; Steven J. Buskirk; Michael G. Heckman; Julia E. Crook; Stephen J. Ko; Michael J. Wehle; Todd C. Igel; Karin Prussak; Thomas M. Pisansky
PURPOSEnTo evaluate late toxicity in patients who received salvage external beam radiotherapy (EBRT) for a detectable prostate-specific antigen (PSA) level after radical prostatectomy (RP).nnnMETHODSnA cohort of 308 consecutive patients underwent salvage EBRT from July 1987 through June 2003 for a detectable PSA level after RP. All were treated with high-energy photons (6-20 MV) to a median dose of 64.8 Gy (range: 54.0-72.4 Gy) in 1.8- to 2.0-Gy fractions.nnnRESULTSnMedian follow-up from the completion of EBRT was 60 months (range: 1 day-174 months). Late toxicity occurring more than 90 days after EBRT completion was identified in 41 patients (13%). Twelve patients (3.9%) had grade 2 urethral strictures and were treated with urethral dilation, 3 patients had grade 3 cystitis, and 1 had a grade 4 rectal complication. These numbers correspond to an estimated 0.7% (95% confidence interval, 0.0-1.6%) of patients experiencing a grade 3 or 4 complication by 5 years after the start of EBRT.nnnCONCLUSIONSnSalvage EBRT for a detectable PSA level after RP is the only curative treatment in this setting. This treatment can be administered in a manner that results in a low likelihood of late complications.
Urology | 2011
David D. Thiel; Paul R. Young; Michael J. Wehle; Gregory A. Broderick; Steven P. Petrou; Todd C. Igel
INTRODUCTIONnThe da Vinci Surgical System has become extremely popular in the field of urology for procedures requiring complex reconstructive maneuvers, such as radical prostatectomy and pyeloplasty. A natural extension of these procedures is the use of the da Vinci system for complex urinary tract reconstruction deep in the pelvis, such as bladder diverticulectomy.nnnTECHNICAL CONSIDERATIONSnIn our report and accompanying Video, we have demonstrated some technical tips and tricks with regard to patient selection, preoperative imaging, patient positioning, port placement, intraoperative diverticulum recognition/excision, and cystotomy repair that the surgeon might find beneficial for successful completion of robotic-assisted bladder diverticulectomy.nnnCONCLUSIONSnThe tips and tricks we have presented might aid in the successful completion of robotic bladder diverticulectomy.
Archive | 2016
David D. Thiel; Paul R. Young; Michael J. Wehle; Gregory A. Broderick; Steven P. Petrou; Todd C. Igel
Clinical Radiation Oncology (Fourth Edition) | 2016
William W. Wong; Jennifer L. Peterson; Winston Tan; Michael G. Haddock; Alexander S. Parker; Michael J. Wehle; Ryan Hutchinson
The Journal of Urology | 2011
Alexander S. Parker; Adam J. Clemens; Andrea Tavlarides; Nancy N. Diehl; Michael G. Heckman; Michael J. Wehle
Urology | 2007
David D. Thiel; Paul R. Young; Gregory A. Broderick; Michael G. Heckman; Michael J. Wehle; Todd C. Igel; ve Steven P. Petrou
The Journal of Urology | 2007
Alexander S. Parker; Christine M. Lohse; Kevin J. Wu; John A. Copland; Michael J. Wehle; John C. Cheville
The Journal of Urology | 2006
David D. Thiel; Paul R. Young; Steven P. Petrou; Gregory A. Broderick; Michael J. Wehle; Todd C. Igel
The Journal of Urology | 2005
Alexander S. Parker; Steven J. Buskirk; Michael G. Heckman; Tim Pisansky; Karen A. Prussak; Michael J. Wehle; Robert G. Ferrigni; Steven E. Schild; Robert P. Myers